coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Eastbourne East PCN, Eastbourne · Health Inequalities Profile

    PCN U48056 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    36,483

    Registered population

    54.5% aged 18–64

    27.1%

    Aged 65+

    ICB 21.9% · England 17.9%

    6.5%

    Ethnic minority (non-White)

    2.2% Asian · England 9.6%

    8.3%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~2,923

    Core20 residents (est.)

    Resident basis; registered basis ~2,890 · see page 3

    6,393

    Hypertension register

    +5.17% in 3 yrs · England +5.60%

    337

    SMI register

    20.8% of Eastbourne's

    892

    COPD register

    Reviews +11.42% in 3 yrs

    Forecast to 2030

    7,054

    Hypertension patients, 2030

    +661 on today

    70.8%

    QRISK ≥20% on statins, 2030

    +4.08pp over 3 yrs

    6.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    66.6%
    Hypertension and lipid control trail England.

    Hypertension treatment to target is 66.6% (England 70.3%), under-80 BP control 63.5% (England 67.8%), and QRISK ≥ 20% lipid therapy 61.8% (England 63.6%).

    10.9 pp
    Age-five MMR drops between doses.

    Age-5 MMR coverage drops 10.9 pp from 90.6% at dose 1 to 79.7% at dose 2 (England 82.8%, NHS Sussex ICB 87.1%, target 95.0%).

    +35.4%
    Asthma review rate rose over three years.

    Asthma reviews rose +35.4% over 2023 to 2025 to 66.7% (England 65.7%), though an estimated 806 of 2,421 registered patients remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Registered patients aged 65+ reach 27.1%, well above England's 17.9% average

    Across three practices serving 36,483 registered patients, 27.1% (9,906) are aged 65+, above Eastbourne (24.2%), NHS Sussex ICB (21.9%) and England (17.9%). Working-age adults (18–64) comprise 54.5% (Eastbourne 58.6%, ICB 60.5%, England 62.7%) and children (0–17) 18.3% (Eastbourne 17.2%, ICB 17.7%, England 19.6%). Census resident data indicates 93.5% White ethnicity (Eastbourne 90.8%, ICB 91.0%, England 81.1%), with a 6.5% ethnic minority share. Projected list growth to 2030 is an unverified 0.6% (Eastbourne 1.1%, ICB 2.1%, England 2.3%). This older profile may elevate PCN chronic disease burden.

    Age profile

    0–1718.3%
    18–6454.5%
    65+27.1%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White93.5%
    Asian2.2%
    Mixed2.2%
    Other1.1%
    Black0.9%

    Older people · falls rows are Eastbourne local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Eastbourne LA)2,3252,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.0%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.2%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Eastbourne LA)1,2219819552024/25
    Falls deaths, all ages, per 100,000 (Eastbourne LA)7.714.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation is 8.3% overall but reaches 14.25% at Harbour Medical Practice

    The PCN Core20 share is 8.3% (about 2,900 residents), below Eastbourne (19.5%), NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Weighted practice share is 7.9%. Across captured practices, the Core20 range is 8.7 pp. Stone Cross Surgery records 5.59% (847 estimated patients). Sovereign Practice records 6.99% (960 estimated patients). Harbour Medical Practice leads at 14.25% (1,083 estimated patients). Proactive outreach and multi-condition reviews should prioritise practice Core20 workload rather than applying a flat PCN allocation.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Harbour Medical14.2% · 1,083 patients
    Sovereign7.0% · 960 patients
    Stone Cross5.6% · 847 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    337

    SMI register

    0.94% recorded prevalence

    198

    Learning disability register

    0.55% recorded prevalence

    16

    Care homes, 718 beds

    In the PCN catchment

    9.7%

    Provide unpaid care

    Eastbourne, Census 2021

    The PCN records 337 patients on the severe mental illness register (0.9%, Eastbourne 1.5%, NHS Sussex ICB 1.1%, England 1.0%) and 198 with learning disabilities (0.6%, Eastbourne 0.8%, ICB 0.6%, England 0.6%). Catchment care homes provide 718 beds across 16 sites; Eastbourne recorded 29 rough sleepers in autumn 2025.

    Severe mental illness: physical health checks

    SMI physical health checks trail England for blood pressure (79.3% vs 83.4%), BMI (76.8% vs 82.1%) and alcohol recording (76.8% vs 81.8%), with blood pressure checks at Stone Cross Surgery at 69.5%, which may reflect recall gaps to audit.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,393

    Hypertension register

    +5.17%

    Register growth, 3 yrs

    Eastbourne +5.24% · England +5.60%

    +3.77pp

    BP control, under 80

    ≤140/90 · +0.37pp aged 80+

    +661

    More patients by 2030

    Forecast 7,054 (19.71%)

    Hypertension case-finding and control

    Hypertension prevalence is 17.8% (6,393 patients), above Eastbourne (17.5%), NHS Sussex ICB (16.3%) and England (15.2%). Recent blood pressure recording reaches 88.3% (England 90.0%). However, treatment to target is 66.6% (England 70.3%), with control in under-80s at 63.5% (England 67.8%) and in ages 80+ at 77.8% (England 81.2%). By practice, under-80 control ranges from 62.4% at Stone Cross Surgery to 63.8% at Sovereign Practice and 64.7% at Harbour Medical Practice. Crude prevalence is not age-adjusted. Blood pressure control trails national benchmarks despite high recorded prevalence, which may reflect medication titration or recall gaps to test through audit.

    Lipids and statins

    Statin coverage for QRISK 20% or higher is 61.8% (England 63.6%, Eastbourne 60.9%, NHS Sussex ICB 60.0%). For patients with diabetes and CVD, statin treatment is 81.7% (England 84.4%), falling 1.4% over 2023 to 2025 (England +1.0%). Lower coverage may reflect follow-up gaps to test through clinical audit.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202675,338£2.00£2.42£1.86£150,676
    Cardiovascular (all), 2025101,025£2.70£3.32£3.33£272,768

    In 2026, the PCN prescribed 75,338 lipid-regulating items at £2.00 per item (£150,676 spend), compared with £1.86 in England, £2.09 in Eastbourne and £2.42 in NHS Sussex ICB. Spend was £10,547 more than at England's unit cost, but £31,642 less than at NHS Sussex Integrated Care Board's.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +35.40%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.61%

    Asthma prevalence, PCN 3-yr % change

    Asthma QOF prevalence is 7.1% (2,421 patients). Annual reviews rose +35.4% over 2023 to 2025 (England +4.4%) to 66.7% (England 65.7%), leaving an estimated 806 patients without a recorded review. Prescribing of asthma management items for ages 5–19 is 2,293 per 1,000 (England 1,488; Eastbourne 2,006). COPD prevalence is 2.5% (892 patients), while annual reviews trail England at 71.9% (England 76.4%, NHS Sussex ICB 74.2%), which may indicate follow-up gaps to audit.

    Cancer register and children's immunisation

    Cancer QOF prevalence is 5.2% (1,863 patients; England 3.8%). In Q1 2025/26, age-5 MMR coverage drops 10.9 pp from dose 1 (90.6%) to dose 2 (79.7%, trailing England's 82.8% and below the 95.0% target by 15.3 pp). Pre-school 4-in-1 booster coverage also matches 79.7% across 64 children. Drop-off between doses may reflect recall barriers to test through audit.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months85.7%

    England 91.0%

    6-in-1 complete primary course at 24 months94.8%

    England 92.2%

    MMR dose 1 at 24 months92.2%

    England 88.3%

    MMR dose 2 at age 579.7%

    England 82.8%

    4-in-1 pre-school booster at age 579.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    Across NHS Sussex ICB in 2022, 58.5% of cancers with a known stage (4,799 of 8,209) were diagnosed at stage 1 or 2, exceeding England (55.3%) by 3.2 percentage points but sitting 16.5 pp below the 75.0% national ambition by 2028. Staging completeness was 64.3% (8,209 of 12,766 registered cancers), meaning staging is incomplete and site-specific counts can be small. Reaching the ambition requires about 1,360 additional early-stage diagnoses annually across the ICB. While the early-stage share increased +5 pp from 53.4% in 2013, early diagnosis remains lower in lung (30.3%) and bowel (49.8%). These system metrics do not reflect PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, East Sussex Healthcare NHS Trust achieved 84.2% on the 28-day faster diagnosis standard (standard 75.0%), ahead of University Hospitals Sussex NHS Foundation Trust (74.0%), Maidstone and Tunbridge Wells NHS Trust (81.8%), NHS Surrey and Sussex Integrated Care Board (79.3%) and England (79.3%). The trust met the 31-day standard at 98.2% (standard 96.0%). However, 62-day referral to treatment was 67.0%, 18.0 pp below the 85.0% standard (ICB 71.5%, England 71.2%). Trust diagnostic 6-week waits were 5.3% (England 23.1%). These hospital metrics do not reflect PCN performance.

    Pathways within standard (%)East Sussex HealthcareSussexMaidstone and Tunbridge WellsSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)84.2074.0181.7879.2979.32
    31-day treatment (96%)98.1976.7998.3590.4592.50
    62-day referral to treatment (85%)67.0465.2087.4371.5171.16
    Diagnostic waits over 6 weeks (%)East Sussex HealthcareSussexMaidstone and Tunbridge WellsEngland
    MRI6.485.620.9221.40
    CT0.488.570.519.92
    Echocardiography21.940.392.5728.48
    Colonoscopy0.7439.3519.8030.83
    Gastroscopy0.3120.0224.0329.02
    All 15 DM01 tests5.2712.956.4223.14
    Community services activityEast Sussex residentsSurrey and Sussex ICB
    Care contacts100,740309,615
    Referrals17,28566,930
    Patients with a contact25,88085,660

    Community services (residents of East Sussex), Jun 2026 (provisional). In June 2026, provisional community services statistics recorded 105,045 care activities and 100,740 care contacts across 25,880 patients residing in East Sussex, alongside 316,320 activities and 309,615 contacts across NHS Surrey and Sussex Integrated Care Board. Adults aged 65+ accounted for 68% of East Sussex contacts (68,465 contacts). These local authority figures reflect wider community activity, not PCN performance.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    In 2025/26, overall QOF achievement exceeded England (92.5%), from 93.4% at Sovereign Practice to 99.2% at Stone Cross Surgery. Vaccination achievement spanned 27.7 pp, from 71.2% at Sovereign Practice to 98.9% at Stone Cross Surgery (England 55.2%), which may reflect variation in recall systems to test via practice audit.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Harbour Medical11414.249.1%68.6%74.5%
    Stone Cross1175.640.0%75.2%72.9%
    Sovereign Practice1037.028.2%71.3%68.1%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNEastbourneAssetPCNEastbourne
    Care homes (catchment)16 (718 beds)n/aSchools (catchment)24n/a
    Children's centres12Places of worship1446
    Libraries13Homelessness support (VCS)0no data
    Day centres (VCS)11Carers support groups (VCS)n/a1
    Primary schools (LA maintained)58Primary academies822
    Special schoolsn/a1

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school MMR and booster recall

    In Q1 2025/26 across 64 children aged 5, MMR coverage drops 10.9 pp from 90.6% at dose 1 to 79.7% at dose 2 (England 82.8%, NHS Sussex ICB 87.1%). For discussion: practices could audit age-five cohorts missing second MMR and 4-in-1 booster doses and test reminder contacts before school entry. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Structured asthma annual review recall

    Asthma review coverage is 66.7% (England 65.7%, Eastbourne 52.3% after +35.4% growth over 2023 to 2025), leaving an estimated 806 of 2,421 registered patients unreviewed. For discussion: the PCN could run structured asthma recall using a single review template alongside inhaler checks, prioritising higher Core20 practices. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Learning disability register validation

    Learning disability QOF prevalence is 0.6% (198 patients), matching England (0.6%) and NHS Sussex ICB (0.6%) but below Eastbourne (0.8%), with an unadjusted gap range of +16 to +86 patients. For discussion: practices could validate learning disability coding against clinical records and explore social-care record cross-checking where data sharing exists. Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Targeted Core20 proactive outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check audit (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension treatment review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Second dose MMR recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Primary care cancer safety netting (p7)Cancers diagnosed at stage 1 or 2 (All cancer sites)—ICB
    Option 1 · Pre-school MMR and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Structured asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15